I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lim, Endry H. T
23
results:
Search for persons
X
Format
Online (23)
Mediatypes
Articles (Online) (10)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
87. The safety and efficacy advantage of blocking C5a vs C5..:
Burnett, Bruce P
;
Lim, Endry H T
;
Vlaar, Alexander
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
2
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a ..:
Lim, Endry H. T.
;
Vlaar, Alexander P. J.
;
de Bruin, Sanne
...
Intensive Care Medicine Experimental. 11 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
3
Cystic fibrosis transmembrane conductance regulator modulat..:
Asmus, Erik
;
Karle, Weronika
;
Brack, Markus C.
...
European Respiratory Journal. 61 (2023) 3 - p. 2202009 , 2023
Link:
https://doi.org/10.1183/..
?
4
Targeting C5a is beneficial in critically ill COVID-19 pati..:
Lim, Endry H.T.
;
Vlaar, Alexander P.J.
;
Brouwer, Matthijs C.
.
Immunobiology. 228 (2023) 6 - p. 152743 , 2023
Link:
https://doi.org/10.1016/..
?
5
EXpert consensus On Diaphragm UltraSonography in the critic..:
Haaksma, Mark E.
;
Smit, Jasper M.
;
Boussuges, Alain
...
Critical Care. 26 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
6
The anti‐C5a antibody vilobelimab efficiently inhibits C5a ..:
Vlaar, Alexander P. J.
;
Lim, Endry H. T.
;
de Bruin, Sanne
...
Clinical and Translational Science. 15 (2022) 4 - p. 854-858 , 2022
Link:
https://doi.org/10.1111/..
?
7
LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vi..:
Mourvillier, Bruno
;
Vlaar, Alexander
;
Witzenrath, Martin
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
8
Anti-C5a antibody vilobelimab treatment and the effect on b..:
Lim, Endry H. T.
;
Vlaar, Alexander P. J.
;
Bos, Lieuwe D. J.
...
Respiratory Research. 23 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
9
Aged versus fresh autologous platelet transfusion in a two‐..:
van Baarle, Floor L. F.
;
de Bruin, Sanne
;
Bulle, Esther B.
...
Transfusion. 62 (2022) 12 - p. 2490-2501 , 2022
Link:
https://doi.org/10.1111/..
?
10
Complement inhibition in severe COVID-19 – Blocking C5a see..:
Lim, Endry H.T.
;
Vlaar, Alexander P.J.
;
de-Bruin, Sanne
..
EClinicalMedicine. 35 (2021) - p. 100722 , 2021
Link:
https://doi.org/10.1016/..
?
11
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a ..:
Lim, Endry H. T
;
Vlaar, Alexander P. J
;
de Bruin, Sanne
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277268/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a ..:
Lim, Endry H. T
;
Vlaar, Alexander P. J
;
de Bruin, Sanne
...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s40635-023-00520-8. , 2023
Link:
https://hal.science/hal-..
?
13
Cystic fibrosis transmembrane conductance regulator modulat..:
Asmus, Erik
;
Karle, Weronika
;
Brack, Markus C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033930/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
14
The anti‐C5a antibody vilobelimab efficiently inhibits C5a ..:
Vlaar, Alexander P. J
;
Lim, Endry H. T
;
de Bruin, Sanne
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010279/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Anti-C5a antibody vilobelimab treatment and the effect on b..:
Lim, Endry H. T
;
Vlaar, Alexander P. J
;
Bos, Lieuwe D. J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789513/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15
